Experimental models for the development of new medical treatments in prostate cancer

被引：7
作者：
Chauchereau, Anne [1 ]
机构：
[1] Inst Gustave Roussy, INSERM, Prostate Canc Grp, U981, F-94805 Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
STEM-LIKE CELLS; ACTIVE ANDROGEN RECEPTOR; TUMOR-GROWTH; PRECLINICAL EVALUATION; COMBINATION THERAPY; OSTEOLYTIC LESIONS; XENOGRAFT MODELS; LNCAP MODEL; MOUSE MODEL; BONE;
D O I：
10.1016/S0959-8049(11)70166-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S200 / S214
页数：15
相关论文
共 99 条
  • [1] Abate-Shen C, 2003, CANCER RES, V63, P3886
  • [2] Al Nakouzi N, 2011, AACR M ORL, P1597
  • [3] Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer
    Chauchereau, Anne
    Al Nakouzi, Nader
    Gaudin, Catherine
    Le Moulec, Sylvestre
    Compagno, Daniel
    Auger, Nathalie
    Benard, Jean
    Opolon, Paule
    Rozet, Francois
    Validire, Pierre
    Fromont, Gaelle
    Fizazi, Karim
    [J]. EXPERIMENTAL CELL RESEARCH, 2011, 317 (03) : 262 - 275
  • [4] Molecular determinants of resistance to antiandrogen therapy
    Chen, CD
    Welsbie, DS
    Tran, C
    Baek, SH
    Chen, R
    Vessella, R
    Rosenfeld, MG
    Sawyers, CL
    [J]. NATURE MEDICINE, 2004, 10 (01) : 33 - 39
  • [5] Chlenski A, 2001, PROSTATE, V47, P66
  • [6] Prospective identification of tumorigenic prostate cancer stem cells
    Collins, AT
    Berry, PA
    Hyde, C
    Stower, MJ
    Maitland, NJ
    [J]. CANCER RESEARCH, 2005, 65 (23) : 10946 - 10951
  • [7] LuCaP 35: A new model of prostate cancer progression to androgen independence
    Corey, E
    Quinn, JE
    Buhler, KR
    Nelson, PS
    Macoska, JA
    True, LD
    Vessella, RL
    [J]. PROSTATE, 2003, 55 (04) : 239 - 246
  • [8] Establishment and characterization of osseous prostate cancer models: Intra tibial injection of human prostate cancer cells
    Corey, E
    Quinn, JE
    Bladou, F
    Brown, LG
    Roudier, MP
    Brown, JM
    Buhler, KR
    Vessella, RL
    [J]. PROSTATE, 2002, 52 (01) : 20 - 33
  • [9] Craft N, 1999, CANCER RES, V59, P5030
  • [10] A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer
    Dahmani, Ahmed
    de Plater, Ludmilla
    Guyader, Charlotte
    Fontaine, Jean-Jacques
    Berniard, Aurelie
    Assayag, Franck
    Beuzeboc, Philippe
    Marangoni, Elisabetta
    Nemati, Fariba
    Poupon, Marie-France
    Pasik, Christophe
    Oudard, Stephane
    Decaudin, Didier
    [J]. ANTI-CANCER DRUGS, 2010, 21 (10) : 927 - 931
12345678910